Cargando…
Vancomycin-Induced Hemolytic Anemia
Drug-induced hemolytic anemia is rare and can occur either by an immune-mediated mechanism or a non-immune-mediated mechanism. The drugs most frequently associated with immune-mediated hemolysis are penicillins and cephalosporins. It is usually difficult to distinguish drug-induced hemolysis from ot...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195073/ https://www.ncbi.nlm.nih.gov/pubmed/37216133 http://dx.doi.org/10.7759/cureus.39191 |
_version_ | 1785044148378664960 |
---|---|
author | Siddiqui, Fakeha Cheema, Ahmad Kamran, Amir |
author_facet | Siddiqui, Fakeha Cheema, Ahmad Kamran, Amir |
author_sort | Siddiqui, Fakeha |
collection | PubMed |
description | Drug-induced hemolytic anemia is rare and can occur either by an immune-mediated mechanism or a non-immune-mediated mechanism. The drugs most frequently associated with immune-mediated hemolysis are penicillins and cephalosporins. It is usually difficult to distinguish drug-induced hemolysis from other more common causes of hemolysis; therefore, a high index of clinical suspicion is required to make the diagnosis. In this case report, we present a case of vancomycin-induced immune hemolytic anemia in a 75-year-old patient who developed hemolytic anemia after starting vancomycin for joint infection. Hematological parameters improved after the discontinuation of vancomycin. Mechanism and management of drug-induced immune hemolytic anemia are also reviewed in this report. |
format | Online Article Text |
id | pubmed-10195073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-101950732023-05-19 Vancomycin-Induced Hemolytic Anemia Siddiqui, Fakeha Cheema, Ahmad Kamran, Amir Cureus Internal Medicine Drug-induced hemolytic anemia is rare and can occur either by an immune-mediated mechanism or a non-immune-mediated mechanism. The drugs most frequently associated with immune-mediated hemolysis are penicillins and cephalosporins. It is usually difficult to distinguish drug-induced hemolysis from other more common causes of hemolysis; therefore, a high index of clinical suspicion is required to make the diagnosis. In this case report, we present a case of vancomycin-induced immune hemolytic anemia in a 75-year-old patient who developed hemolytic anemia after starting vancomycin for joint infection. Hematological parameters improved after the discontinuation of vancomycin. Mechanism and management of drug-induced immune hemolytic anemia are also reviewed in this report. Cureus 2023-05-18 /pmc/articles/PMC10195073/ /pubmed/37216133 http://dx.doi.org/10.7759/cureus.39191 Text en Copyright © 2023, Siddiqui et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Siddiqui, Fakeha Cheema, Ahmad Kamran, Amir Vancomycin-Induced Hemolytic Anemia |
title | Vancomycin-Induced Hemolytic Anemia |
title_full | Vancomycin-Induced Hemolytic Anemia |
title_fullStr | Vancomycin-Induced Hemolytic Anemia |
title_full_unstemmed | Vancomycin-Induced Hemolytic Anemia |
title_short | Vancomycin-Induced Hemolytic Anemia |
title_sort | vancomycin-induced hemolytic anemia |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195073/ https://www.ncbi.nlm.nih.gov/pubmed/37216133 http://dx.doi.org/10.7759/cureus.39191 |
work_keys_str_mv | AT siddiquifakeha vancomycininducedhemolyticanemia AT cheemaahmad vancomycininducedhemolyticanemia AT kamranamir vancomycininducedhemolyticanemia |